dan 2163 has been researched along with Cognitive Dysfunction in 2 studies
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Raafat, RS | 1 |
Habib, MZ | 1 |
AbdElfattah, AA | 1 |
Olama, NK | 1 |
Abdelraouf, SM | 1 |
Hendawy, N | 1 |
Kamal, KA | 1 |
Nawishy, SA | 1 |
Aboul-Fotouh, S | 1 |
Park, CH | 1 |
Park, TW | 1 |
Yang, JC | 1 |
Lee, KH | 1 |
Huang, GB | 1 |
Tong, Z | 1 |
Park, MS | 1 |
Chung, YC | 1 |
1 trial available for dan 2163 and Cognitive Dysfunction
Article | Year |
---|---|
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Bli | 2012 |
1 other study available for dan 2163 and Cognitive Dysfunction
Article | Year |
---|---|
Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats.
Topics: Amisulpride; Animals; beta Catenin; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunct | 2023 |